Shirotake S - Search Results

1

Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report.

Hoshino Y, Kanao K, Miyama Y, Kosaka T, Kaneko G, Shirotake S, Yasuda M, Oyama M. Hoshino Y, et al. Among authors: shirotake s. Int Cancer Conf J. 2024 Apr 18;13(3):250-255. doi: 10.1007/s13691-024-00673-7. eCollection 2024 Jul. Int Cancer Conf J. 2024. PMID: 38962044 Free PMC article.

2

Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.

Kosaka T, Miyajima A, Shirotake S, Kikuchi E, Hasegawa M, Mikami S, Oya M. Kosaka T, et al. Among authors: shirotake s. Prostate. 2010 Feb 1;70(2):162-9. doi: 10.1002/pros.21049. Prostate. 2010. PMID: 19760626

3

Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.

Shirotake S, Kikuchi E, Matsumoto K, Yazawa S, Kosaka T, Miyajima A, Nakagawa K, Oya M. Shirotake S, et al. Jpn J Clin Oncol. 2010 Mar;40(3):247-51. doi: 10.1093/jjco/hyp147. Epub 2009 Nov 3. Jpn J Clin Oncol. 2010. PMID: 19887521

4

Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.

Kosaka T, Kikuchi E, Mikami S, Miyajima A, Shirotake S, Ishida M, Okada Y, Oya M. Kosaka T, et al. Among authors: shirotake s. Clin Cancer Res. 2010 Dec 1;16(23):5814-23. doi: 10.1158/1078-0432.CCR-10-0230. Epub 2010 Oct 14. Clin Cancer Res. 2010. PMID: 20947514

5

Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.

Tanaka N, Miyajima A, Kosaka T, Shirotake S, Hasegawa M, Kikuchi E, Oya M. Tanaka N, et al. Among authors: shirotake s. Mol Cancer Ther. 2010 Nov;9(11):2982-92. doi: 10.1158/1535-7163.MCT-10-0535. Epub 2010 Oct 26. Mol Cancer Ther. 2010. PMID: 20978160

6

Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer.

Shirotake S, Miyajima A, Kosaka T, Tanaka N, Maeda T, Kikuchi E, Oya M. Shirotake S, et al. Urology. 2011 Apr;77(4):1009.e19-25. doi: 10.1016/j.urology.2010.11.002. Epub 2011 Feb 5. Urology. 2011. PMID: 21296393

7

Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.

Kosaka T, Miyajima A, Shirotake S, Kikuchi E, Oya M. Kosaka T, et al. Among authors: shirotake s. Prostate. 2011 Oct 1;71(14):1510-7. doi: 10.1002/pros.21367. Epub 2011 Feb 14. Prostate. 2011. PMID: 21321983

8

Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer.

Hasegawa M, Miyajima A, Kosaka T, Yasumizu Y, Tanaka N, Maeda T, Shirotake S, Ide H, Kikuchi E, Oya M. Hasegawa M, et al. Among authors: shirotake s. Int J Cancer. 2012 Jan 15;130(2):431-42. doi: 10.1002/ijc.26012. Epub 2011 Apr 25. Int J Cancer. 2012. PMID: 21351099

9

Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer.

Kosaka T, Miyajima A, Shirotake S, Suzuki E, Kikuchi E, Oya M. Kosaka T, et al. Among authors: shirotake s. J Urol. 2011 Jun;185(6):2376-81. doi: 10.1016/j.juro.2011.02.016. Epub 2011 Apr 20. J Urol. 2011. PMID: 21511293

10

A case of angiomyolipoma of the renal sinus.

Shirotake S, Yoshimura I, Kosaka T, Matsuzaki S. Shirotake S, et al. Clin Exp Nephrol. 2011 Dec;15(6):953-6. doi: 10.1007/s10157-011-0519-9. Epub 2011 Aug 17. Clin Exp Nephrol. 2011. PMID: 21847520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters